AstraZeneca backs $1bn China biotech fund for smaller ventures – Financial Times
AstraZeneca has signalled its confidence in China’s biotech sector by partnering with state-owned investment bank CICC on a $1bn fund to invest in local start-ups.
The Anglo-Swedish drugmaker would contribute a “substantial” amount to the fund, which would h…
